Zobrazeno 1 - 10
of 263
pro vyhledávání: '"E, Benner"'
Autor:
Harini Natarajan, Shiwei Xu, Andrew R. Crowley, Savannah E. Butler, Joshua A. Weiner, Evan M. Bloch, Kirsten Littlefield, Sarah E. Benner, Ruchee Shrestha, Olivia Ajayi, Wendy Wieland-Alter, David Sullivan, Shmuel Shoham, Thomas C. Quinn, Arturo Casadevall, Andrew Pekosz, Andrew D. Redd, Aaron A. R. Tobian, Ruth I. Connor, Peter F. Wright, Margaret E. Ackerman
Publikováno v:
BMC Immunology, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background While antibodies can provide significant protection from SARS-CoV-2 infection and disease sequelae, the specific attributes of the humoral response that contribute to immunity are incompletely defined. Methods We employ machine le
Externí odkaz:
https://doaj.org/article/034c463115724341925f58490be90688
Autor:
Sarah E. Benner, Yolanda Eby, Xianming Zhu, Reinaldo E. Fernandez, Eshan U. Patel, Jessica E. Ruff, Feben Habtehyimer, Haley A. Schmidt, Charles S. Kirby, Sarah Hussain, Darin Ostrander, Niraj M. Desai, Sander Florman, Meenakshi M. Rana, Rachel Friedman-Moraco, Marcus R. Pereira, Shikha Mehta, Peter Stock, Alexander Gilbert, Michele I. Morris, Valentina Stosor, Sapna A. Mehta, Catherine B. Small, Karthik Ranganna, Carlos A.Q. Santos, Saima Aslam, Jennifer Husson, Maricar Malinis, Nahel Elias, Emily A. Blumberg, Brianna L. Doby, Allan B. Massie, Melissa L. Smith, Jonah Odim, Thomas C. Quinn, Gregory M. Laird, Robert F. Siliciano, Dorry L. Segev, Andrew D. Redd, Christine M. Durand, Aaron A.R. Tobian
Publikováno v:
JCI Insight, Vol 7, Iss 21 (2022)
The HIV latent viral reservoir (LVR) remains a major challenge in the effort to find a cure for HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow transplantation to reduce the LVR. This study evaluated the LVR
Externí odkaz:
https://doaj.org/article/09d1623efd834d26a727f8f8faacd04a
Autor:
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, Shiwei Xu, Joshua A. Weiner, Evan M. Bloch, Kirsten Littlefield, Wendy Wieland-Alter, Ruth I. Connor, Peter F. Wright, Sarah E. Benner, Tania S. Bonny, Oliver Laeyendecker, David Sullivan, Shmuel Shoham, Thomas C. Quinn, H. Benjamin Larman, Arturo Casadevall, Andrew Pekosz, Andrew D. Redd, Aaron A. R. Tobian, Margaret E. Ackerman
Publikováno v:
mBio, Vol 12, Iss 2 (2021)
Convalescent plasma has been deployed globally as a treatment for COVID-19, but efficacy has been mixed. Better understanding of the antibody characteristics that may contribute to its antiviral effects is important for this intervention as well as o
Externí odkaz:
https://doaj.org/article/06bc9967a2e644a7be0d758babdbd5ad
Autor:
James C Romero-Masters, Shane M Huebner, Makoto Ohashi, Jillian A Bristol, Bayleigh E Benner, Elizabeth A Barlow, Gail L Turk, Scott E Nelson, Dana C Baiu, Nicholas Van Sciver, Erik A Ranheim, Jenny Gumperz, Nathan M Sherer, Paul J Farrell, Eric C Johannsen, Shannon C Kenney
Publikováno v:
PLoS Pathogens, Vol 16, Iss 2, p e1008365 (2020)
Humans are infected with two distinct strains (Type 1 (T1) and Type 2 (T2)) of Epstein-Barr virus (EBV) that differ substantially in their EBNA2 and EBNA 3A/B/C latency genes and the ability to transform B cells in vitro. While most T1 EBV strains co
Externí odkaz:
https://doaj.org/article/ec69057eebe34560b5bc126ef97ce47f
Autor:
Rachel M. Miller, Rachel A. Knoener, Bayleigh E. Benner, Brian L. Frey, Mark Scalf, Michael R. Shortreed, Nathan M. Sherer, Lloyd M. Smith
Publikováno v:
J Proteome Res
Human immunodeficiency virus type 1 (HIV-1) remains a deadly infectious disease despite existing antiretroviral therapies. A comprehensive understanding of the specific mechanisms of viral infectivity remains elusive and currently limits the developm
Autor:
Sarah E, Benner, Debra L, Walter, Jean R, Thuma, Maria, Courreges, Calvin B L, James, Frank L, Schwartz, Kelly D, McCall
Publikováno v:
Pancreas. 51:48-55
Genetic and environmental influences play a role as triggers of type 1 diabetes mellitus (T1DM). Female nonobese diabetic (NOD) mice are useful for studying T1DM as they spontaneously develop T1DM, which can be accelerated by some viruses. Toll-like
Autor:
Karyna Rosario, Kaitlin A. Mettel, Bayleigh E. Benner, Ryan Johnson, Catherine Scott, Sohath Z. Yusseff-Vanegas, Christopher C.M. Baker, Deby L. Cassill, Caroline Storer, Arvind Varsani, Mya Breitbart
Publikováno v:
PeerJ, Vol 6, p e5761 (2018)
Viruses encoding a replication-associated protein (Rep) within a covalently closed, single-stranded (ss)DNA genome are among the smallest viruses known to infect eukaryotic organisms, including economically valuable agricultural crops and livestock.
Externí odkaz:
https://doaj.org/article/7f0b5ffe96b041c790d7fe7e2d027580
Autor:
Abraham J. Kandathil, Sarah E. Benner, Evan M. Bloch, Ruchee Shrestha, Olivia Ajayi, Xianming Zhu, Patrizio P. Caturegli, Shmuel Shoham, David Sullivan, Kelly Gebo, Thomas C. Quinn, Arturo Casadevall, Daniel Hanley, Andrew Pekosz, Andrew D. Redd, Ashwin Balagopal, Aaron A. R. Tobian
Publikováno v:
TransfusionREFERENCES.
It is important to maintain the safety of blood products by avoiding the transfusion of units with known and novel viral pathogens. It is unknown whether COVID-19 convalescent plasma (CCP) may contain pathogenic viruses (either newly acquired or reac
Autor:
Morgan Keruly, Imani Burgess, Jernelle Miller, Aaron A.R. Tobian, Patrizio Caturegli, Andrew Pekosz, Eshan U. Patel, William Clarke, Andrew D. Redd, David J. Sullivan, Yolanda Eby, Owen R Baker, Evan M. Bloch, Haley A Schmidt, Ruchee Shrestha, Tania S. Bonny, Thomas C. Quinn, Ethan Klock, Kirsten Littlefield, Arturo Casadevall, Charles S Kirby, Oliver Laeyendecker, Sarah E. Benner, Reinaldo E Fernandez, Shmuel Shoham
Publikováno v:
The Journal of Infectious Diseases
Background Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. However, not all recovered patients develop adequate antibody titers for do
Autor:
Karen T. Coschigano, Sarah E Benner, Ramiro Malgor, Kelly D. McCall, Debra L. Walter, Rosemary Jane Oaks, Frank L. Schwartz, Jean R. Thuma
Publikováno v:
Viral Immunol
End-stage renal disease (ESRD) is described by four primary diagnoses, diabetes, hypertension, glomerulonephritis, and cystic kidney disease, all of which have viruses implicated as causative agents. Enteroviruses, such as coxsackievirus (CV), are a